Pulmonary Fibrosis Symptoms, Diagnosis, Prognosis and Treatment

October 20, 2017October 20, 2017
Interview: RECAP Trial Confirms Esbriet’s Long-Term Safety Profile
Esbriet, News
Results from the RECAP clinical trial, which was conducted over five years, support the long-term safety of Esbriet ( ... Read more
October 19, 2017October 18, 2017
My Time-sensitive Bucket List
Columns, Younger than 30: Living with IPF, a column by Charlene Marshall
When talking to others about things they would like to do someday, it is common to hear people respond ... Read more
October 19, 2017October 19, 2017
Breathlessness and Cough Signal Pulmonary Fibrosis Years Before Diagnosis, Study Reports
News
Patients with idiopathic pulmonary fibrosis (IPF) are likely to experience symptoms for years before their diagnosis, a ... Read more
October 18, 2017October 18, 2017
Bacteria-derived Protein Halts Fibrosis-promoting Cells’ Invasion of Lungs, Study Shows
News
A small bacterial protein called R1R2 reduced fibrosis-promoting cells’ ability to go from the blood, where they normally reside, ... Read more
October 16, 2017October 16, 2017
Illness, Caregiving and Feeling Vulnerable
Columns, Younger than 30: Living with IPF, a column by Charlene Marshall
As my idiopathic pulmonary fibrosis (IPF) progresses, I have been having multiple discussions with my personal and professional ... Read more
October 16, 2017October 16, 2017
Pulmonary Rehab Should Be Among ‘First Line’ Therapies for IPF and Other Lung Diseases, Study Argues
News
Pulmonary rehabilitation programs can significantly improve exercise ability, breathing, and overall quality of life in patients with ... Read more
October 13, 2017October 13, 2017
Ofev Delays IPF Progression Beyond 52 Weeks, Results from TOMORROW Extension Trial Show
News
Long-term use of Boehringer Ingelheim’s Ofev (nintedanib) prevents disease progression in patients with idiopathic pulmonary fibrosis (IPF), ... Read more
October 12, 2017October 11, 2017
Adjusting to Pain: The Reality of Living with IPF
Columns, Younger than 30: Living with IPF, a column by Charlene Marshall
As I sit down to write this column, I am consciously aware of, and thinking specifically about, where I ... Read more
October 12, 2017October 12, 2017
RUNX2 Protein Plays Different Roles in Two Lung Cell Types’ Contribution to Fibrosis, Study Reports
News
A protein called RUNX2 contributes to lung tissue scarring, which makes it a good target for the development of ... Read more
October 11, 2017October 11, 2017
MicroRNA Molecule Blocks Fibroblast Activity, Proliferation in Mice with Lung Fibrosis, Study Finds
News
A small RNA molecule, called microRNA 101, prevents the proliferation and activation of fibroblasts, thereby eliminating pulmonary fibrosis (PF) ... Read more
October 10, 2017October 9, 2017
Keeping Your Oxygen Provider Happy
Columns, Just Breathe...Compassionate Help for the PF Journey
As a pulmonary fibrosis patient, being on supplemental oxygen 24/7 is quite a challenge. There is a lot to ... Read more
October 9, 2017October 9, 2017
I’m Sorry For Canceling Plans, Again
Columns, Younger than 30: Living with IPF, a column by Charlene Marshall
Lately, it feels as if I spend most of my time apologizing to friends and family for canceling plans. ... Read more

October 20, 2017October 20, 2017

Interview: RECAP Trial Confirms Esbriet’s Long-Term Safety Profile

Results from the RECAP clinical trial, which was conducted over five years, support the long-term safety of Esbriet (pirfenidone) in patients with idiopathic pulmonary fibrosis (IPF). The study, “An Open-Label ... Read more

October 19, 2017October 18, 2017

My Time-sensitive Bucket List

Columns, Younger than 30: Living with IPF, a column by Charlene Marshall

When talking to others about things they would like to do someday, it is common to hear people respond with, “That’s on my bucket list.” Whether it’s traveling around ... Read more

October 19, 2017October 19, 2017

Breathlessness and Cough Signal Pulmonary Fibrosis Years Before Diagnosis, Study Reports

News

Patients with idiopathic pulmonary fibrosis (IPF) are likely to experience symptoms for years before their diagnosis, a British study reports. University of Nottingham researchers analyzed symptoms in the medical charts ... Read more

October 18, 2017October 18, 2017

Bacteria-derived Protein Halts Fibrosis-promoting Cells’ Invasion of Lungs, Study Shows

News

A small bacterial protein called R1R2 reduced fibrosis-promoting cells’ ability to go from the blood, where they normally reside, to lung tissue, a mouse study shows. The research, “R1R2 ... Read more

October 16, 2017October 16, 2017

Illness, Caregiving and Feeling Vulnerable

Columns, Younger than 30: Living with IPF, a column by Charlene Marshall

As my idiopathic pulmonary fibrosis (IPF) progresses, I have been having multiple discussions with my personal and professional networks about how they can best support me. Most of the ... Read more

October 16, 2017October 16, 2017

Pulmonary Rehab Should Be Among ‘First Line’ Therapies for IPF and Other Lung Diseases, Study Argues

News

Pulmonary rehabilitation programs can significantly improve exercise ability, breathing, and overall quality of life in patients with pulmonary diseases, including idiopathic pulmonary fibrosis (IPF), and should be considered as ... Read more

October 13, 2017October 13, 2017

Ofev Delays IPF Progression Beyond 52 Weeks, Results from TOMORROW Extension Trial Show

News

Long-term use of Boehringer Ingelheim’s Ofev (nintedanib) prevents disease progression in patients with idiopathic pulmonary fibrosis (IPF), according to the latest results of the TOMORROW trial and its open-label ... Read more

October 12, 2017October 11, 2017

Adjusting to Pain: The Reality of Living with IPF

Columns, Younger than 30: Living with IPF, a column by Charlene Marshall

As I sit down to write this column, I am consciously aware of, and thinking specifically about, where I feel pain in my body. Right now, both of my ... Read more

October 12, 2017October 12, 2017

RUNX2 Protein Plays Different Roles in Two Lung Cell Types’ Contribution to Fibrosis, Study Reports

News

A protein called RUNX2 contributes to lung tissue scarring, which makes it a good target for the development of a pulmonary fibrosis treatment, a study reported. It does this differently ... Read more

October 11, 2017October 11, 2017

MicroRNA Molecule Blocks Fibroblast Activity, Proliferation in Mice with Lung Fibrosis, Study Finds

News

A small RNA molecule, called microRNA 101, prevents the proliferation and activation of fibroblasts, thereby eliminating pulmonary fibrosis (PF) in mice, researchers at Oklahoma State University (OSU) have found. Their ... Read more

October 10, 2017October 9, 2017

Keeping Your Oxygen Provider Happy

Columns, Just Breathe...Compassionate Help for the PF Journey

As a pulmonary fibrosis patient, being on supplemental oxygen 24/7 is quite a challenge. There is a lot to adjust being tied to a cannula all the time, which ... Read more

October 9, 2017October 9, 2017

I’m Sorry For Canceling Plans, Again

Columns, Younger than 30: Living with IPF, a column by Charlene Marshall

Lately, it feels as if I spend most of my time apologizing to friends and family for canceling plans. Before being diagnosed with idiopathic pulmonary fibrosis (IPF), I rarely ... Read more